Jove
Visualize
Contact Us

Related Concept Videos

Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

1.3K
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
1.3K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

421
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
421
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

321
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
321
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

3.6K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.6K
Hypertension I: Introduction01:28

Hypertension I: Introduction

640
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
640
Measurement of Blood Pressure01:17

Measurement of Blood Pressure

2.5K
Assessing blood pressure is a standard procedure executed in virtually all medical environments. The method utilized today was established over a hundred years ago by an innovative Russian doctor, Dr. Nikolai Korotkoff. The soft ticking noise, known as Korotkoff sounds, heard while taking blood pressure readings results from turbulent blood flow within the vessels. The apparatus required for this procedure includes a sphygmomanometer, a blood pressure cuff attached to a gauge, and a...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CAV1-dependent mitochondrial transfer from hucMSCs reprograms epithelial lipid metabolism to relieve pulmonary fibrosis.

Stem cell research & therapy·2026
Same author

Myocardial rhythm-mediated lipid metabolic dysfunction participates in adverse cardiac remodeling in offspring exposed to PM2.5 during conception.

Ecotoxicology and environmental safety·2025
Same author

STAT3 Facilitates Super Enhancer Formation to Promote Fibroblast-To-Myofibroblast Differentiation by the Analysis of ATAC-Seq, RNA-Seq and ChIP-Seq.

Journal of cellular and molecular medicine·2025
Same author

circELP2 reverse-splicing biogenesis and function as a pro-fibrogenic factor by targeting mitochondrial quality control pathway.

Journal of cellular and molecular medicine·2023
Same author

Proteomic analysis reveals the aging-related pathways contribute to pulmonary fibrogenesis.

Aging·2023
Same author

Chalcogen Bonding Catalysis of the Cloke-Wilson Rearrangement.

Chemistry (Weinheim an der Bergstrasse, Germany)·2023
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 4, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

A Machine-Learning-Based Prediction Method for Hypertension Outcomes Based on Medical Data.

Wenbing Chang1, Yinglai Liu1, Yiyong Xiao1

  • 1School of Reliability and Systems Engineering, Beihang University, Beijing 100191 China.

Diagnostics (Basel, Switzerland)
|November 10, 2019
PubMed
Summary
This summary is machine-generated.

Predicting hypertension outcomes like stroke is crucial. This study introduces a new method using physical exam data and machine learning to accurately forecast these serious complications, improving patient care.

Keywords:
XGBoostclassification algorithmfeature selectionhypertension outcomespredictionrecursive feature elimination

More Related Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.9K

Related Experiment Videos

Last Updated: Jan 4, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.9K

Area of Science:

  • Cardiology
  • Medical Informatics
  • Machine Learning in Healthcare

Background:

  • Hypertension outcomes, including myocardial infarction and stroke, pose significant risks.
  • Current methods for predicting hypertension-related complications are inadequate.
  • Accurate prediction of hypertension outcomes is essential for timely intervention and improved patient management.

Purpose of the Study:

  • To develop and validate a novel prediction method for hypertension outcomes.
  • To identify key physical examination indicators for predicting patient outcomes.
  • To enhance the accuracy of predicting serious complications in hypertensive patients.

Main Methods:

  • A two-step approach was employed: feature extraction and outcome prediction.
  • Recursive feature elimination with cross-validation (RFE-CV) was used for optimal feature selection.
  • Four classification algorithms (SVM, C4.5, RF, XGBoost) were evaluated for outcome prediction using selected features.

Main Results:

  • The RFE-CV method effectively identified optimal feature subsets for prediction.
  • Classifiers utilizing selected features demonstrated improved prediction performance.
  • Extreme Gradient Boosting (XGBoost) achieved the highest performance with 94.36% accuracy, 0.875 F1-score, and 0.927 AUC.

Conclusions:

  • The proposed method effectively predicts hypertension outcomes using physical examination data.
  • Machine learning models, particularly XGBoost, show strong potential for clinical application in hypertension management.
  • This approach offers a practical tool for identifying high-risk patients and preventing severe complications.